|
Re: DSMB
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 04:46PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:27AM
|
|
Re: Statistically proven...
|
4
|
Resverlogix Corp.
|
Sep 12, 2019 10:34PM
|
|
Re: Resverlogix AGM webcast 9/12/2018
|
4
|
Resverlogix Corp.
|
Sep 10, 2018 06:16PM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
4
|
Resverlogix Corp.
|
Jul 28, 2020 10:44AM
|
|
Re: While we wait, outside items that may be of interest
|
4
|
Resverlogix Corp.
|
Aug 23, 2017 01:00PM
|
|
Life Science Report: Resverlogix Seeks Orphan Status for Lead Drug Candidate
|
4
|
Resverlogix Corp.
|
Aug 04, 2016 07:42AM
|
|
Re: Some thoughts on DM and the back and forth of compounds..
|
4
|
Resverlogix Corp.
|
Aug 30, 2015 04:41PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
4
|
Zenith Epigenetics
|
Oct 17, 2019 02:41PM
|
|
Re: To moderator / forum boss
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 23, 2018 12:10AM
|
|
American Heart Association 2017
|
4
|
Resverlogix Corp.
|
Sep 26, 2017 05:26AM
|
|
BRD4/Nrf2/ARE signaling is implicated in the pathogenesis of diabetic nephropathy
|
4
|
Resverlogix Corp.
|
Jul 24, 2019 02:59PM
|
|
Re: Position Sizing and Odds of Success
|
4
|
Resverlogix Corp.
|
Apr 26, 2019 10:22AM
|
|
Re: Three Great Posts on Investor Village
|
4
|
Resverlogix Corp.
|
Oct 18, 2016 02:00PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Jun 28, 2017 10:37AM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
4
|
Resverlogix Corp.
|
Sep 26, 2017 07:52AM
|
|
Notice of Meeting and Management Information Circular Posted
|
4
|
Zenith Epigenetics
|
Sep 28, 2019 07:52AM
|
|
Re: Japanese publication response from IR
|
4
|
Zenith Epigenetics
|
Nov 12, 2016 04:10PM
|
|
Re: Apabetalone Treatment of CKD Patientsis Associated with Favorable Kidney Function and Alkaline Phosphatase Profile
|
4
|
Resverlogix Corp.
|
Mar 23, 2018 10:11AM
|
|
Re: Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
|
4
|
Resverlogix Corp.
|
May 17, 2017 12:29PM
|
